home > publications
View:
Publications
 
Jasmine Foo
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. (2009)
Foo J, Drummond MW, Clarkson B, Holyoake T, Michor F
PLoS Comput Biol. 2009 Sep;5(9):e1000503.
 
Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies. (2009)
Foo J, Michor F
PLoS Comput Biol. 2009 Nov;5(11):e1000557.
 
Algorithm Refinement for the Stochastic Burgers Equation (2007)
J. Bell, J. Foo, A. Garcia
Journal of Computational Physics (2007) Vol 223 : 451-468
 
Stochastic Simulation of Riser-Sections with Uncertain Measured Pressure Loads and/or Uncertain Material Properties (2007)
J. Foo, Z. Yosibash, G. Karniadakis
CMAME (2007) Vol 196: 4250-4271
 
Vortex mode selection of a rigid cylinder subject to VIV at low mass-damping (2005)
D. Lucor, J. Foo, G. Karniadakis
Journal of Fluids and Structures (2005) Vol 20: 485-503
 
Correlation Length and Force Phasing of a Rigid Cylinder Subject to VIV of Fully Coupled Fluid Structure Interactions (2004)
D. Lucor, J. Foo, G. Karniadakis
In: Fluid Mechanics and its Applications, Vol. 75
Springer
ISBN: 1402018061
 
Hiroshi Haeno
A progenitor cell origin of myeloid malignancies. (2009)
Haeno H, Levine RL, Gilliland DG, Michor F
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21.
 
The evolution of two mutations during clonal expansion. (2007)
Haeno H, Iwasa Y, Michor F
Genetics. 2007 Dec;177(4):2209-21.
 
Probability of resistance evolution for exponentially growing virus in the host. (2007)
Haeno H, Iwasa Y
J Theor Biol. 2007 May 21;246(2):323-31.
 
Franziska Michor
Evolutionary theory of cancer. (2009)
Attolini CS, Michor F
Ann N Y Acad Sci. 2009 Jun;1168:23-51.
 
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. (2009)
Foo J, Drummond MW, Clarkson B, Holyoake T, Michor F
PLoS Comput Biol. 2009 Sep;5(9):e1000503.
 
Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies. (2009)
Foo J, Michor F
PLoS Comput Biol. 2009 Nov;5(11):e1000557.
 
A progenitor cell origin of myeloid malignancies. (2009)
Haeno H, Levine RL, Gilliland DG, Michor F
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21.
 
Mathematical models of cancer stem cells. (2008)
Michor F
J Clin Oncol. 2008 Jun 10;26(17):2854-61.
 
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1). (2008)
Liso A, Castiglione F, Cappuccio A, Stracci F, Schlenk RF, Amadori S, Thiede C, Schnittger S, Valk PJ, D??hner K, Martelli MF, Schaich M, Krauter J, Ganser A, Martelli MP, Bolli N, L??wenberg B, Haferlach T, Ehninger G, Mandelli F, D??hner H, Michor F, Falini B
Haematologica. 2008 Jul 4;
 
Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia. (2007)
Michor F
Trends Pharmacol Sci. 2007 May;28(5):197-9.
 
(A)symmetric stem cell replication and cancer. (2007)
Dingli D, Traulsen A, Michor F
PLoS Comput Biol. 2007 Mar 16;3(3):e53.
 
The emergence of tumor metastases. (2007)
Dingli D, Michor F, Antal T, Pacheco JM
Cancer Biol Ther. 2007 Mar;6(3):383-90.
 
Chronic myeloid leukemia blast crisis arises from progenitors. (2007)
Michor F
Stem Cells. 2007 May;25(5):1114-8.
 
The evolution of two mutations during clonal expansion. (2007)
Haeno H, Iwasa Y, Michor F
Genetics. 2007 Dec;177(4):2209-21.
 
Mathematical models of targeted cancer therapy. (2006)
Abbott LH, Michor F
Br J Cancer. 2006 Nov 6;95(9):1136-41.
 
The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. (2006)
Michor F, Iwasa Y, Nowak MA
Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14931-4.
 
Successful therapy must eradicate cancer stem cells. (2006)
Dingli D, Michor F
Stem Cells. 2006 Dec;24(12):2603-10.
 
Evolution of resistance during clonal expansion. (2006)
Iwasa Y, Nowak MA, Michor F
Genetics. 2006 Apr;172(4):2557-66.
 
Dynamics of metastasis suppressor gene inactivation. (2006)
Michor F, Iwasa Y
J Theor Biol. 2006 Aug 7;241(3):676-89.
 
Evolution of resistance to cancer therapy. (2006)
Michor F, Nowak MA, Iwasa Y
Curr Pharm Des. 2006;12(3):261-71.
 
Genetic instability and clonal expansion. (2006)
Nowak MA, Michor F, Iwasa Y
J Theor Biol. 2006 Jul 7;241(1):26-32.
 
Genetic instability and the quasispecies model. (2006)
Brumer Y, Michor F, Shakhnovich EI
J Theor Biol. 2006 Jul 21;241(2):216-22.
 
Stochastic dynamics of metastasis formation. (2006)
Michor F, Nowak MA, Iwasa Y
J Theor Biol. 2006 Jun 21;240(4):521-30.
 
Synergy and discounting of cooperation in social dilemmas. (2006)
Hauert C, Michor F, Nowak MA, Doebeli M
J Theor Biol. 2006 Mar 21;239(2):195-202.
 
Dynamics of colorectal cancer. (2005)
Michor F, Iwasa Y, Lengauer C, Nowak MA
Semin Cancer Biol. 2005 Dec;15(6):484-93.
 
Dynamics of chronic myeloid leukaemia. (2005)
Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, Nowak MA
Nature. 2005 Jun 30;435(7046):1267-70.
 
Chromosomal instability and human cancer. (2005)
Michor F
Philos Trans R Soc Lond B Biol Sci. 2005 Mar 29;360(1455):631-5.
 
Population genetics of tumor suppressor genes. (2005)
Iwasa Y, Michor F, Komarova NL, Nowak MA
J Theor Biol. 2005 Mar 7;233(1):15-23.
 
Can chromosomal instability initiate tumorigenesis? (2005)
Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA
Semin Cancer Biol. 2005 Feb;15(1):43-9.
 
Virus evolution within patients increases pathogenicity. (2005)
Iwasa Y, Michor F, Nowak MA
J Theor Biol. 2005 Jan 7;232(1):17-26.
 
Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. (2004)
Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, Hahn BH, Nowak MA, Shaw GM, Borrow P
J Exp Med. 2004 Nov 15;200(10):1243-56.
 
Evolutionary dynamics of tumor suppressor gene inactivation. (2004)
Nowak MA, Michor F, Komarova NL, Iwasa Y
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10635-8.
 
Some basic properties of immune selection. (2004)
Iwasa Y, Michor F, Nowak M
J Theor Biol. 2004 Jul 21;229(2):179-88.
 
Stochastic tunnels in evolutionary dynamics. (2004)
Iwasa Y, Michor F, Nowak MA
Genetics. 2004 Mar;166(3):1571-9.
 
Dynamics of cancer progression. (2004)
Michor F, Iwasa Y, Nowak MA
Nat Rev Cancer. 2004 Mar;4(3):197-205.
 
Linear model of colon cancer initiation. (2004)
Michor F, Iwasa Y, Rajagopalan H, Lengauer C, Nowak MA
Cell Cycle. 2004 Mar;3(3):358-62.
 
Evolutionary dynamics of invasion and escape. (2004)
Iwasa Y, Michor F, Nowak MA
J Theor Biol. 2004 Jan 21;226(2):205-14.
 
Evolutionary dynamics of escape from biomedical intervention. (2003)
Iwasa Y, Michor F, Nowak MA
Proc Biol Sci. 2003 Dec 22;270(1533):2573-8.
 
The linear process of somatic evolution. (2003)
Nowak MA, Michor F, Iwasa Y
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14966-9.
 
Somatic selection for and against cancer. (2003)
Michor F, Frank SA, May RM, Iwasa Y, Nowak MA
J Theor Biol. 2003 Dec 7;225(3):377-82.
 
Stochastic elimination of cancer cells. (2003)
Michor F, Nowak MA, Frank SA, Iwasa Y
Proc Biol Sci. 2003 Oct 7;270(1528):2017-24.
 
Local regulation of homeostasis favors chromosomal instability. (2003)
Michor F, Iwasa Y, Komarova NL, Nowak MA
Curr Biol. 2003 Apr 1;13(7):581-4.
 
Evolution: the good, the bad and the lonely. (2002)
Michor F, Nowak MA
Nature. 2002 Oct 17;419(6908):677, 679.
 
Camille Stephan-Otto
Evolutionary theory of cancer. (2009)
Attolini CS, Michor F
Ann N Y Acad Sci. 2009 Jun;1168:23-51.
 
Generic Darwinian selection in catalytic protocell assemblies. (2007)
Munteanu A, Attolini CS, Rasmussen S, Ziock H, Sol?? RV
Philos Trans R Soc Lond B Biol Sci. 2007 Oct 29;362(1486):1847-55.
 
Sloan-Kettering Institute Memorial Sloan-Kettering Cancer Center